반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2([CH3:30])[C:12]([C:14]3[CH:19]=[CH:18][C:17]([Cl:20])=[CH:16][CH:15]=3)([CH3:13])[NH:11][C:10]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[O:27][CH2:28][CH3:29])=[N:9]2)=[CH:4][CH:3]=1.[C:31](Cl)([Cl:33])=[O:32]>C(N(CC)CC)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2([CH3:30])[C:12]([C:14]3[CH:19]=[CH:18][C:17]([Cl:20])=[CH:16][CH:15]=3)([CH3:13])[N:11]([C:31]([Cl:33])=[O:32])[C:10]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[O:27][CH2:28][CH3:29])=[N:9]2)=[CH:6][CH:7]=1참가 물질
4
실험 절차
In a manner analogous to the method described in example 3, rac-(4S*,5R*)-4,5-bis-(4-chloro-phenyl)-2-(2-ethoxy-phenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole was reacted with phosgene in the presence of triethylamine to give the title compound.
출처 및 근거
- ORD 기록
- ord-8c57ab80e14e42d287ceb005d905ce04
- 출처 데이터셋
- uspto-grants-2010_12
- 특허 번호
- US07851626B2
연결된 노트
불러오는 중…